跳至主要内容
临床试验/JPRN-jRCT2080223545
JPRN-jRCT2080223545未知1 期

Phase 1/2 Study of ONO-4538 in Japanese Participants with Sepsis or Septic Shock

ONO PHARMACEUTICAL CO.,LTD.0 个研究点目标入组 10 人开始时间: 2017年5月30日最近更新:

试验速览

阶段
1 期
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Documented or suspected infection
  • 2. Severe sepsis or septic shock for at least 24 hours
  • 3. Sepsis-induced immunosuppression
  • 4. In Intensive Care Unit (ICU) with no plans to discharge in next 24 hours

排除标准

  • 1. Previous episode of severe sepsis or septic shock with ICU admission during the current hospitalization
  • 2. Autoimmune disease
  • 3. Organ or bone marrow transplant
  • 4. Known history of malignancy and has an anticipated survival of < 3 months
  • 5. Human immunodeficiency virus (HIV) infection and not on therapy prior to this episode of sepsis; hepatitis C virus(HCV) infection; Chronic hepatitis B virus (HBV) infection and not on treatment

研究者

发起方
ONO PHARMACEUTICAL CO.,LTD.

相似试验